A novel CD123xVδ2 bispecific T cell engager induces potent and tumor selective Vγ9Vδ2-T cell activity against CD123 expressing acute myeloid leukemia and myelodysplastic syndrome

Jurjen M. Ruben, Charlotte M. Mousset, Dorien van de Berg, Kim Hofman, Milon de Jong, Patricia Brouwer, Sanne Graeve, Victoria Iglesias-Guimarais, Pauline M. van Helden, Anton E.P. Adang, Rob C. Roovers, Hans J. van der Vliet
Clinical Immunology · Elsevier · DOI: 10.1016/j.clim.2026.110786

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles